FDA product code PCO: Immunoglobulin G Lambda Heavy And Light Chain Combined
PCO is the FDA product code for immunoglobulin g lambda heavy and light chain combined. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel. Devices under PCO reach the market by 510(k); FDA lists no cleared 510(k)s for it.
Definition
Intended for the in-vitro quantification of IgG lambda concentration in human serum. The result is to be used with previously diagnosed IgG multiple myeloma, in conjunction with other clinical and laboratory findings.
Classification
| Field | Value |
|---|---|
| Device name | Immunoglobulin G Lambda Heavy And Light Chain Combined |
| Device class | Class II |
| Regulation | 21 CFR 866.5510 |
| Review panel | IM — Immunology |
| Medical specialty | Immunology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
Recalls for PCO devices
FDA recall records list no recalls for product code PCO.
Frequently asked questions
What is FDA product code PCO?
PCO is the FDA product code for immunoglobulin g lambda heavy and light chain combined. It is a Class II device, regulated under 21 CFR 866.5510 and reviewed by the Immunology panel.
What device class is PCO?
Class II, regulation 21 CFR 866.5510. Typical premarket route: 510(k).
Next steps
- Run an FDA pathway report with predicate devices for product code PCO
- Run a recall and safety report across every PCO manufacturer
- Watch product code PCO for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Immunology product codes · FDA product code lookup · 510(k) database search · 510(k) review times